Use of Water Ingestion in Small Intestine Ultrasound
Use of Water Ingestion to Improve Visualisation in Small Intestine Ultrasound (WIVIUS): Single Centre Blinded Crossover Trial
1 other identifier
observational
55
1 country
1
Brief Summary
Small Intestine Contrast Ultrasonography (SICUS) is an ultrasound-based method that explores bowel loops, and is able to identify wall thickness, intestinal motility, bowel wall vascularity and complications such as stenosis or dilatation. Previous studies have utilised oral ingestion of an oral contrast solution (usually PEG dissolved in a volume of water ranging from 250 to 1000mL), in order to increase the sensitivity of ultrasound, especially in stricture detection. Parameters that have been improved include lumen distension to better delineate bowel wall layers, and improved peristalsis. Diffusion of this technique has been limited, in part due to PEG-based agents being costly, time consuming and are not tolerated well in some individuals. Utilisation of water as oral contrast may improve patient tolerability and therefore increase uptake of water ingested intestinal contrast ultrasound (WICUS) as a technique in routine clinical practice. The investigators aim to study the tolerability and the improvement of image quality utilising water as an oral contrast for intestinal ultrasonography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 22, 2025
June 1, 2025
4 months
June 30, 2025
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of luminal distension of the terminal ileum
Improvement of luminal distension of the terminal ileum, defined as increase of 20% over baseline luminal diameter at the terminal ileum if no disease, taking the average as measured at 1cm intervals over 3cm of the TI in longitudinal view. If diseased segment is present, then measurements would be done at 1cm intervals over 3cm proximal to the diseased segments.
At the post-water ingestion scan 20-30 minutes after ingestion
Secondary Outcomes (1)
Is image quality and visualisation of the terminal/distal ileum improved post water ingestion during intestinal ultrasound compared to baseline as assessed by blinded sonographers
At the time of post-water ingestion scan 20-30 minutes after ingestion
Other Outcomes (9)
Grade of peristalsis
At the time of post-water ingestion scan 20-30 mins after ingestion
Identification of suspected stricture
At the post-water ingestion scan 20-30 minutes after ingestion
Measurement of bowel wall thickness
At the post-water ingestion scan 20-30 minutes after ingestion
- +6 more other outcomes
Study Arms (1)
IUS oral contrast
All patients already referred and scheduled to undertake an IUS in the single-centre IUS clinic would undergo a baseline procedure. Patients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care. Inclusion Criteria All consecutive patients at baseline scan with: Confirmed or suspected Crohn's disease with small bowel involvement Increased bowel wall thickness (\>3mm) of the terminal ileum Suboptimal luminal distension of the terminal ileum 3cm proximal to ICV and 1cm proximal to diseased segment (defined as \<8mm) All patients with an ileo-colic anastomosis Exclusion Criteria Presence of an ostomy Adequate distension at baseline scan Patients with ileo-rectal anastomosis or IPAA
Interventions
Patients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care.
Eligibility Criteria
All patients already referred and scheduled to undertake an IUS in the single-centre Austin Health IUS clinic would undergo a baseline procedure. Patients that meet the inclusion and exclusion criteria would be asked to ingest 1000ml water as part of standard of care.
You may qualify if:
- All consecutive patients at baseline scan with:
- Confirmed or suspected Crohn's disease with small bowel involvement
- Increased bowel wall thickness (\>3mm) of the terminal ileum
- Suboptimal luminal distension of the terminal ileum 3cm proximal to ICV and 1cm proximal to diseased segment (defined as \<8mm)
- All patients with an ileo-colic anastomosis
You may not qualify if:
- Presence of an ostomy
- Adequate distension at baseline scan
- Patients with ileo-rectal anastomosis or IPAA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Austin Healthlead
Study Sites (1)
Austin Health
Heidelberg, Victoria, 3084, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator: Julien Schulberg, MBBS, PhD , Austin Health, Melbourne
Study Record Dates
First Submitted
June 30, 2025
First Posted
July 22, 2025
Study Start
July 1, 2025
Primary Completion
November 1, 2025
Study Completion
February 1, 2026
Last Updated
July 22, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share